Journal Watch · Clinical Pharmacology & Therapeutics · 2026

Modeling Supports Combinatorial Effects Between Pharmacological and Non-Pharmacological Interventions to Prevent Opioid-Induced Cardiac Arrest.

Our results highlight the importance of utilizing both pharmacological and non-pharmacological interventions in reversal of overdose.

Thrasher B, Mann J, Chaturbedi A et al.Clinical Pharmacology & Therapeutics3 min readPharma relevance 60/100

DOI: 10.1002/cpt.70186PMID: 41520183Study type: research study

TL;DR

Our results highlight the importance of utilizing both pharmacological and non-pharmacological interventions in reversal of overdose.

Key findings

  • Even in cases where virtual subjects survived without naloxone, 4 mg intranasal naloxone provided benefit by shortening the time to recovery of spontaneous.
  • Our results highlight the importance of utilizing both pharmacological and non-pharmacological interventions in reversal of overdose.

Numbers at a glance (from the abstract)

5%

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Our model showed that timely rescue breathing reduced the naloxone dose needed for successful overdose reversal from greater than 8 mg (intranasal) to less than 2 mg (intramuscular) and extended the naloxone rescue window to 10 minutes under a median fentanyl intravenous overdose scenario. Administration of 4 mg naloxone intranasally reduced the duration of rescue breathing needed from 11 hours to 5 minutes under a median fentanyl transmucosal overdose scenario. High-quality (as delivered by well-trained rescuers), but not low-quality (as delivered by laypersons), rescue breathing could successfully rescue severe opioid overdose scenarios.

Full abstract (original)

Background: Few studies have quantified the effects of non-pharmacological interventions (e.g., rescue breathing) in the setting of community opioid overdose. We extended a previously validated model for opioid antagonists by incorporating the mechanism of rescue breathing, and quantified combinatorial effects between rescue breathing and various formulations of naloxone under different fentanyl overdose scenarios in a virtual patient population suffering from opioid-induced respiratory failure. We defined successful reversal of an overdose as fewer than 5% of the virtual population experiencing cardiac arrest after intervention.

What they did: Our model showed that timely rescue breathing reduced the naloxone dose needed for successful overdose reversal from greater than 8 mg (intranasal) to less than 2 mg (intramuscular) and extended the naloxone rescue window to 10 minutes under a median fentanyl intravenous overdose scenario. Administration of 4 mg naloxone intranasally reduced the duration of rescue breathing needed from 11 hours to 5 minutes under a median fentanyl transmucosal overdose scenario. High-quality (as delivered by well-trained rescuers), but not low-quality (as delivered by laypersons), rescue breathing could successfully rescue severe opioid overdose scenarios.

Results & conclusions: Even in cases where virtual subjects survived without naloxone, 4 mg intranasal naloxone provided benefit by shortening the time to recovery of spontaneous. Our results highlight the importance of utilizing both pharmacological and non-pharmacological interventions in reversal of overdose.

Abstract © the authors / Clinical Pharmacology & Therapeutics (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1002/cpt.70186 · PubMed 41520183.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Clinical Pharmacology & Therapeutics study find?

Our results highlight the importance of utilizing both pharmacological and non-pharmacological interventions in reversal of overdose.

What type of study is this?

It is a research study, published in Clinical Pharmacology & Therapeutics in 2026. Our model showed that timely rescue breathing reduced the naloxone dose needed for successful overdose reversal from greater than 8 mg (intranasal) to less than 2 mg (intramuscular) and extended the naloxone rescue window to 10 minutes under a median fentanyl intravenous overdose scenario.

Where can I read the original paper?

The original is at the publisher via DOI 10.1002/cpt.70186. PubMed ID: 41520183. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Thrasher B, Mann J, Chaturbedi A et al.. Modeling Supports Combinatorial Effects Between Pharmacological and Non-Pharmacological Interventions to Prevent Opioid-Induced Cardiac Arrest.. Clinical Pharmacology & Therapeutics (2026). DOI: 10.1002/cpt.70186.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/modeling-supports-combinatorial-effects-between-pharmacological-and-non-t70186/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides